SCHEDULE 13G/A
Statement of Beneficial Ownership
Allogene Therapeutics, Inc. Filed Acc 0000902664-26-002534
Loading xslSCHEDULE_13G_X02/primary_doc.xml…
Allogene Therapeutics, Inc. Filed Acc 0000902664-26-002534
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…